Core Insights - Alignment Healthcare, Inc. (ALHC) is a significant player in the Medicare Advantage sector, emphasizing high-quality, member-focused care [1] - The company has achieved a consistent rating of 4 stars or higher for all its Medicare Advantage plans for two consecutive years, reflecting its commitment to exceptional care [3] - ALHC's stock has shown volatility, with a market capitalization of approximately $3.48 billion and a trading volume of over 2 million shares on NASDAQ [5] Company Performance - Chief Medical Officer Kim Hyong sold 51,379 shares at approximately $17.57 each, retaining a substantial holding of 362,333 shares, indicating confidence in the company's future [2][6] - The Texas HMO has received a commendable rating of 4.5 stars in its inaugural year, attributed to the company's focus on the aging population's needs [4] - The stock price has fluctuated between $17.34 and $17.82 on a daily basis, with a yearly high of $21.06 and a low of $10.11 [5]

Core Viewpoint - SelectQuote Inc. is under increased legal scrutiny following a whistleblower lawsuit alleging deceptive sales practices, leading to a significant drop in its stock price and a subsequent class-action lawsuit from investors [1][4]. Legal Issues - The U.S. Department of Justice (DOJ) has intervened in a whistleblower lawsuit against SelectQuote, which claims the company engaged in misleading sales practices related to Medicare Advantage plans [1][3]. - The lawsuit, Pahlkotter v. SelectQuote Inc. et al., includes investors who purchased shares between September 9, 2020, and May 1, 2025, alleging that SelectQuote misrepresented its business model and regulatory risks [2][5]. Allegations of Misconduct - The complaint alleges that SelectQuote misrepresented its sales practices, claiming to provide "unbiased advice" while actually directing customers towards higher-commission plans and accepting illegal kickbacks [3][7]. - The DOJ's complaint indicates that from 2016 to at least 2021, SelectQuote received tens of millions of dollars in improper payments and discriminated against less profitable customers [3][7]. Market Reaction - Following the DOJ's involvement, SelectQuote's stock price fell nearly 20% in a single day, and shares have declined over 40% in the past six months due to investor concerns about legal exposure and reputational damage [4][5]. Investigative Actions - Hagens Berman, a shareholder rights firm, is investigating whether SelectQuote's revenue was artificially inflated through deceptive practices, transforming the situation into a serious federal matter [6].

CVS Health said on Thursday that its Aetna insurance business has over 81% of members in Medicare Advantage plans that are rated 4 stars or higher for 2026. ...

, /PRNewswire/ --Â Aetna®, a CVS Health® company (NYSE: CVS), announced today that over 81 percent of its Medicare Advantage (MA) members are in 2026 Medicare Advantage Prescription Drug (MAPD) plans that are rated 4 stars or higher (out of 5 stars) by the Centers for Medicare & Medicaid Services (CMS). Additionally, over 63 percent of Aetna Medicare Advantage members are in a 4.5-star plan for 2026. "This year's Star Ratings reflect Aetna's strong fundamentals and unwavering commitment to delivering except ...

Core Viewpoint - SelectQuote Inc. is under increased legal scrutiny due to a whistleblower lawsuit alleging deceptive sales practices, leading to a significant drop in its stock price and a subsequent class-action lawsuit from investors [1][5][6] Legal Issues - The U.S. Department of Justice (DOJ) has intervened in a lawsuit claiming SelectQuote engaged in misleading sales practices related to Medicare Advantage plans, resulting in improper payments and discrimination against less profitable customers [4][8] - The class-action lawsuit, Pahlkotter v. SelectQuote Inc. et al., includes investors who purchased shares between September 9, 2020, and May 1, 2025, alleging that the company misrepresented its business model and regulatory risks [2][6] Market Impact - Following the DOJ's involvement, SelectQuote's stock price fell nearly 20% on May 1, 2025, and has since declined over 40% in the past six months, reflecting investor concerns about legal exposure and reputational damage [5][6] Allegations of Misconduct - The lawsuit claims SelectQuote misrepresented its services as providing unbiased advice while allegedly steering customers towards higher-commission plans and accepting illegal kickbacks [4][8] - The DOJ's complaint indicates that SelectQuote's actions may have violated federal statutes, including the False Claims Act [8]

SAN FRANCISCO, Oct. 06, 2025 (GLOBE NEWSWIRE) -- SelectQuote Inc. (NYSE: SLQT), a digital insurance platform known for selling Medicare Advantage plans, is facing heightened legal scrutiny after the U.S. Department of Justice (DOJ) intervened in a whistleblower lawsuit alleging deceptive sales practices. The federal action triggered a sharp 19% drop in SelectQuote’s share price on May 1, 2025, and has now led to a securities class-action lawsuit filed on behalf of investors. The suit, Pahlkotter v. SelectQu ...

Group 1: Health Insurance Sector - Humana (HUM) shares surged nearly 11% after the company affirmed its outlook and provided insights into the quality ratings of its Medicare Advantage plans, leading to strong performance in the S&P 500 [4][9] - Other health insurers also experienced gains, with Centene (CNC) and Cigna (CI) rising by 5.1% and 4.7%, respectively, following Humana's positive update [4] Group 2: Technology Sector - Palantir Technologies (PLTR) shares fell 7.5% after reports indicated vulnerabilities in a battlefield communications network being developed by the company, leading to concerns about security [6][9] - Zebra Technologies (ZBRA) saw a 3% increase in shares after completing the acquisition of Elo Touch Solutions, which is expected to expand its addressable market [5] Group 3: Casino and Gaming Industry - Shares of casino operators declined as Tropical Cyclone Matmo posed a threat to Macau, a key gaming destination, with Las Vegas Sands (LVS) and Wynn Resorts (WYNN) both dropping over 7% [7] Group 4: Retail Sector - Nike (NKE) stock decreased by 3.5% despite reporting better-than-expected sales and profits for its fiscal first quarter, as the company warned of higher tariff costs and declining sales in its classic footwear lines [8]

Humana Inc. (NYSE: HUM ) is one of the biggest companies offering Medicare Advantage plans, covering millions of seniors across the U.S. It goes up against large rivals like UnitedHealth Group Incorporated ( UNH ) and CVS Health Corporation (I focus on producing objective, data-driven research, mostly about small- to mid-cap companies, as these tend to be overlooked by many investors. From time to time, though, I also look at large-cap names, just to give a fuller sense of the broader equity markets.Analyst ...

Group 1 - Humana's stock experienced a significant increase following the disclosure of findings from the government's Star Ratings for its 2026 Medicare Advantage plans [1]

Accessibility StatementSkip Navigation SLQT Investors with Losses Encouraged to Contact Hagens Berman SAN FRANCISCO, Oct. 2, 2025 /PRNewswire/ -- SelectQuote Inc. (NYSE: SLQT), a digital insurance platform known for selling Medicare Advantage plans, is facing heightened legal scrutiny after the U.S. Department of Justice (DOJ) intervened in a whistleblower lawsuit alleging deceptive sales practices. The federal action triggered a sharp 19% drop in SelectQuote's share price on May 1, 2025, and has now led to ...